Metastasis immune-based scores predict patient survival

被引：5
作者：
Mlecnik, Bernhard [1 ,2 ,3 ,4 ]
Bindea, Gabriela [1 ,2 ,3 ]
Van den Eynde, Marc [5 ]
Galon, Jerome [1 ,2 ,3 ]
机构：
[1] INSERM, Lab Integrat Canc Immunol, Paris, France
[2] Equipe Labellisee Ligue Canc, Paris, France
[3] Univ Paris, Sorbonne Univ, Ctr Rech Cordeliers, Paris, France
[4] Inovarion, Paris, France
[5] Univ Catholique Louvain Uclouvain, Clin Univ St Luc, Dept Med Oncol & Hepatogastroenterol, Brussels, Belgium
来源：
ONCOIMMUNOLOGY | 2020年 / 9卷 / 01期
关键词：
Immunoscore; stage IV; tumor microenvironment; cancer classification; prognosis; immunity; metastasis; chemotherapy; pathology; LIVER METASTASES; CHEMOTHERAPY; IMMUNOSCORE;
D O I：
10.1080/2162402X.2020.1806000
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Treatment of metastatic colorectal cancer is based upon the assumption that metastases are homogeneous within a patient. A comprehensive analysis of all metastases of each patient revealed the heterogeneity of the colorectal metastatic disease and its clinical impact. Complex tumor-immune interrelations shape the metastatic landscape. Adaptive immune cells and Immunoscore quantified in a random metastatic biopsy predict clinical outcome and their evaluation in the tumor microenvironment of the least infiltrated metastasis most accurately predict long-term survival. The adaptive immune cell infiltration was more informative than tumor regression and pathological response to predict long-term survival. These results highlight the clinical utility of Immunoscore for patient management. The immune response within the tumor microenvironment is an essential diagnostic criterion for colorectal cancer that has recently been integrated into the international WHO classification of Digestive System Tumors.
引用
收藏
页数：3
相关论文
共 14 条
  • [1] Evolution of Metastases in Space and Time under Immune Selection
    Angelova, Mihaela
    Mlecnik, Bernhard
    Vasaturo, Angela
    Bindea, Gabriela
    Fredriksen, Tessa
    Lafontaine, Lucie
    Buttard, Benedicte
    Morgand, Erwan
    Bruni, Daniela
    Jouret-Mourin, Anne
    Hubert, Catherine
    Kartheuser, Alex
    Humblet, Yves
    Ceccarelli, Michele
    Syed, Najeeb
    Marincola, Francesco M.
    Bedognetti, Davide
    Van den Eynde, Marc
    Galon, Jerome
    [J]. CELL, 2018, 175 (03) : 751 - +
  • [2] Trial Watch Peptide vaccines in cancer therapy
    Aranda, Fernando
    Vacchelli, Erika
    Eggermont, Alexander
    Galon, Jerome
    Sautes-Fridman, Catherine
    Tartour, Eric
    Zitvogel, Laurence
    Kroemer, Guido
    Galluzzi, Lorenzo
    [J]. ONCOIMMUNOLOGY, 2013, 2 (12): : 1 - 11
  • [3] The prognostic impact of anti-cancer immune response: a novel classification of cancer patients
    Bindea, Gabriela
    Mlecnik, Bernhard
    Fridman, Wolf-Herman
    Galon, Jerome
    [J]. SEMINARS IN IMMUNOPATHOLOGY, 2011, 33 (04) : 335 - 340
  • [4] Immunoscore and Immunoprofiling in cancer: an update from the melanoma and immunotherapy bridge 2015
    Galon, J.
    Fox, B. A.
    Bifulco, C. B.
    Masucci, G.
    Rau, T.
    Botti, G.
    Marincola, F. M.
    Ciliberto, G.
    Pages, F.
    Ascierto, P. A.
    Capone, M.
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2016, 14
  • [5] Localization and Density of Immune Cells in the Invasive Margin of Human Colorectal Cancer Liver Metastases Are Prognostic for Response to Chemotherapy
    Halama, Niels
    Michel, Sara
    Kloor, Matthias
    Zoernig, Inka
    Benner, Axel
    Spille, Anna
    Pommerencke, Thora
    Doeberitz, Magnus von Knebel
    Folprecht, Gunnar
    Luber, Birgit
    Feyen, Nadine
    Martens, Uwe M.
    Beckhove, Philipp
    Gnjatic, Sacha
    Schirmacher, Peter
    Herpel, Esther
    Weitz, Juergen
    Grabe, Niels
    Jaeger, Dirk
    [J]. CANCER RESEARCH, 2011, 71 (17) : 5670 - 5677
  • [6] Rational bases for the use of the Immunoscore in routine clinical settings as a prognostic and predictive biomarker in cancer patients
    Kirilovsky, Amos
    Marliot, Florence
    El Sissy, Carine
    Haicheur, Nacilla
    Galon, Jerome
    Pages, Franck
    [J]. INTERNATIONAL IMMUNOLOGY, 2016, 28 (08) : 373 - 382
  • [7] Immune evasion before tumour invasion in early lung squamous carcinogenesis
    Mascaux, Celine
    Angelova, Mihaela
    Vasaturo, Angela
    Beane, Jennifer
    Hijazi, Kahkeshan
    Anthoine, Geraldine
    Buttard, Benedicte
    Rothe, Francoise
    Willard-Gallo, Karen
    Haller, Annick
    Ninane, Vincent
    Burny, Arsene
    Sculier, Jean-Paul
    Spira, Avi
    Galon, Jerome
    [J]. NATURE, 2019, 571 (7766) : 570 - +
  • [8] Comprehensive Intrametastatic Immune Quantification and Major Impact of Immunoscore on Survival
    Mlecnik, Bernhard
    Van den Eynde, Marc
    Bindea, Gabriela
    Church, Sarah E.
    Vasaturo, Angela
    Fredriksen, Tessa
    Lafontaine, Lucie
    Haicheur, Nacilla
    Marliot, Florence
    Debetancourt, Daphne
    Pairet, Geraldine
    Jouret-Mourin, Anne
    Gigot, Jean-Francois
    Hubert, Catherine
    Danse, Etienne
    Dragean, Cristina
    Carrasco, Javier
    Humblet, Yves
    Valge-Archer, Viia
    Berger, Anne
    Galon, Jerome
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2018, 110 (01): : 97 - 108
  • [9] Prognostic and predictive value of the Immunoscore in stage III colon cancer patients treated with oxaliplatin in the prospective IDEA France PRODIGE-GERCOR cohort study y
    Pages, F.
    Andre, T.
    Taieb, J.
    Vernerey, D.
    Henriques, J.
    Borg, C.
    Marliot, F.
    Ben Jannet, R.
    Louvet, C.
    Mineur, L.
    Bennouna, J.
    Desrame, J.
    Faroux, R.
    Kirilovsky, A.
    Duval, A.
    Laurent-Puig, P.
    Svrcek, M.
    Hermitte, F.
    Catteau, A.
    Galon, J.
    Emile, J. -F.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 (07) : 921 - 929
  • [10] The essential role of the in situ immune reaction in human colorectal cancer
    Pages, Franck
    Galon, Jerome
    Fridman, Wolf H.
    [J]. JOURNAL OF LEUKOCYTE BIOLOGY, 2008, 84 (04) : 981 - 987
12